Cml Healthcare Inc news

   Watch this stock
Showing stories 1 - 10 of about 61   

Articles published

CLC 0.0000
price chart
Fighting the battle against cancer
Their family, friends and healthcare providers can provide effective support. ... In an official press release, Dr Sawsan Al Madhi, Secretary General for the FoCP, said: �CML patients are not terminally ill, and with proper medication, can lead full ...
From a mutation: Peshawar reports highest number of chronic myeloid ...
PESHAWAR: As many as 860 patients in Khyber-Pakhtunkhwa (K-P) are suffering from chronic myeloid leukaemia (CML), a form of blood cancer, while every month 15 to 20 people are diagnosed with the disease.
Teva Launches SYNCareTM Home Administration Support Program for Patients ...
SYNRIBO� was recently approved by the U.S. Food and Drug Administration (FDA) for home administration. Adults with chronic or accelerated phase chronic myeloid leukemia (CML) who are no longer responding to, or who could not tolerate, two or more ...
Related articles »  
Natural Killer Cells Could Fight Off ALL
A laboratory study found that CD56+ immune effector cells, or natural killer cells, could be multiplied from the blood of patients with precursor B-lineage acute lymphoblastic leukemia (pre-B ALL), and that those natural killer (NK) cells could be an ...
Deal reached in battle for Southbank undercroft
The Financial Times (subscription required) reports that new mortgage lending in August hit the highest summer levels since the financial crisis, according to the Council of Mortgage Lenders (CML). The newspaper reports that banks and other lenders put ...
Related articles »  
DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent ...
29, 2014 /PR Newswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the Company") today announced the filing of June 30, 2014 fiscal year-end financial statements.
Related articles »  
DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw ...
VANCOUVER British Columbia and MENLO PARK Calif. Aug. 27 2014 /PRNewswire/ -- DelMar Pharmaceuticals Inc. (OTCQB: DMPI) developer of advanced cancer therapeutics will be featured as a presenting company at the 16th Annual Rodman ...
Related articles »  
First-Time Buyers in Greater London in Total Borrow 27% More in the Second ...
New CML data on the characteristics of lending in Greater London in the second quarter of 2014 show the market grew in both house purchase and remortgage activity compared to the previous quarter and the same period last year.
We've moved; where is everything?
For all of you who have been worried to death, let me assure you that we have safely moved. Let me add that I will never again move.
Demand for Predictive Cancer Diagnostics Shoots Up
'Rising in the popularity of predictive cancer tests to fuel the growth of the IVD market', says RNCOS. Noida, UP -- (ReleaseWire) -- 09/11/2014 -- Health conscious individuals are increasingly looking for predictive diagnostic tests for cancer.